Morning versus bedtime insulin glargine in combination with glimepiride: No difference in incidence of nocturnal hypoglycemia in patients with type 2 diabetes

被引：0
|
作者：
Standl, E
Maxeiner, S
Schweitzer, MA
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A134 / A134
页数：1
相关论文
共 50 条
  • [31] Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy
    Yokoyama, Hiroki
    Tada, Junko
    Kamikawa, Futayo
    Kanno, Sakiko
    Yokota, Yuki
    Kuramitsu, Masae
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 73 (01) : 35 - 40
  • [32] MORNING VERSUS BEDTIME ISOPHANE INSULIN IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    SEIGLER, DE
    OLSSON, GM
    SKYLER, JS
    [J]. DIABETIC MEDICINE, 1992, 9 (09) : 826 - 833
  • [33] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [34] Latin American clinical trial project on insulin glargine versus NPH insulin plus glimepiride in Type 2 diabetes.
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    Macêdo, M
    [J]. DIABETOLOGIA, 2003, 46 : A272 - A272
  • [35] Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
    Tarigan, Tri Juli Edi
    Dwijayanti, Adisti
    Setyowati, Susie
    Louisa, Melva
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 107 - 116
  • [36] Confirmed lower risk of hypoglycemia with insulin glargine versus NPH insulin:: A meta-analysis of 2304 patients with type 2 diabetes
    Rosenstock, J
    Benedetti, MM
    Häring, HU
    Salzman, A
    [J]. DIABETES, 2003, 52 : A454 - A454
  • [37] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [38] Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a systematic review and meta-analysis
    Ana Díez-Fernández
    Iván Cavero-Redondo
    Jesús Moreno-Fernández
    Diana P. Pozuelo-Carrascosa
    Miriam Garrido-Miguel
    Vicente Martínez-Vizcaíno
    [J]. Acta Diabetologica, 2019, 56 : 355 - 364
  • [39] Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a systematic review and meta-analysis
    Diez-Fernandez, Ana
    Cavero-Redondo, Ivan
    Moreno-Fernandez, Jesus
    Pozuelo-Carrascosa, Diana P.
    Garrido-Miguel, Miriam
    Martinez-Vizcaino, Vicente
    [J]. ACTA DIABETOLOGICA, 2019, 56 (03) : 355 - 364
  • [40] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    [J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
12345